'Iv heparin' diaporamas de présentation

High-Alert Medications: Safeguarding Against Errors (Part 2)

High-Alert Medications: Safeguarding Against Errors (Part 2). Learning Objectives. Describe examples of specific safety improvements to prevent errors with high-alert medications Outline a framework to examine high-alert drugs in your institution.

619 views • 60 slides

Vascular Disorders: Deep Vein Thrombosis, Pulmonary Embolism, Peripheral Vascular Disease

Vascular Disorders: Deep Vein Thrombosis, Pulmonary Embolism, Peripheral Vascular Disease. Hinkle ch 30, pp 819-838, 600-603. Terminology. Sometimes called thrombophlebitis, phlebothrombosis, venous thrombosis, venous thromboembolism (VTE)

406 views • 39 slides

Vascular Disorders: Deep Vein Thrombosis, Pulmonary Embolism, Peripheral Vascular Disease

Vascular Disorders: Deep Vein Thrombosis, Pulmonary Embolism, Peripheral Vascular Disease. Brunner ch 30, pp 819-842, 600-603. Terminology. Sometimes called thrombophlebitis, phlebothrombosis, venous thrombosis, venous thromboembolism (VTE)

409 views • 39 slides

Adjunctive Therapy for PCI

Adjunctive Therapy for PCI. Neal Uren MD MRCP Department of Cardiology Royal Infirmary of Edinburgh. Determinants of Successful PCI. CLINICAL STATUS LV function Stable vs. unstable angina vs. MI LESION COMPLEXITY AHA/ACC class OPERATOR VOLUME ADJUNCTIVE THERAPY

559 views • 35 slides

Vascular Disorders: Deep Vein Thrombosis, Pulmonary Embolism, Peripheral Vascular Disease

Vascular Disorders: Deep Vein Thrombosis, Pulmonary Embolism, Peripheral Vascular Disease. Brunner ch 31, pp 848-866, 874-884. Terminology. Sometimes called thrombophlebitis, phlebothrombosis, venous thrombosis, venous thromboembolism (VTE)

686 views • 30 slides

FOOT ISCHEMIA FOLLOWING FOAM SCLEROTHERAPY

FOOT ISCHEMIA FOLLOWING FOAM SCLEROTHERAPY. G. Lionel Zumbro, Jr., MD, FACS, RVT, RPVI. HISTORY. 57 yo female underwent RF ablation of left GSV with multiple phlebectomy. Ten days later she had RF ablation of the right GSV.

337 views • 18 slides

Advanced Adult Intravenous Calculations

1.92k views • 13 slides

Heparin-associated 30 Day Mortality

Heparin-associated 30 Day Mortality. Zarychanski et al, CCM 2008;36:2973-9. Heparin-Associated 30 Day Mortality. Adjusted Cox Proportional hazards of mortality with therapeutic dose IV heparin. Zarychanski et al, CCM 2008;36:2973-9. Effect of IV Heparin: 30 Day Mortality. p < .01. p = .05.

205 views • 6 slides